
Read More
20% Returns in 1 Month: This Piramal Group Pharma Stock Reports 17% Revenue...
Piramal Pharma reported healthy Q1 FY27 growth across all three business segments, with strong EBITD...

Piramal Pharma reported healthy Q1 FY27 growth across all three business segments, with strong EBITD...

Piramal Pharma witnessed strong buying interest on Tuesday, with trading volume surging to 348.8 lak...

In the first half of trading session, share price surged more than 15 per cent on the back of heavy ...